---
title: "RGEN: Raised 2026 guidance after strong Q2 growth, margin gains, and BioLife acquisition announcement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294084489.md"
description: "Q2 2026 saw 13% organic revenue growth, margin expansion, and strong performance in proteins and analytics. Full-year guidance was raised for revenue and EPS, with BioLife acquisition set to accelerate cell therapy growth and deliver financial synergies.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-28T14:51:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294084489.md)
  - [en](https://longbridge.com/en/news/294084489.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294084489.md)
generator: "portal-rs"
---

# RGEN: Raised 2026 guidance after strong Q2 growth, margin gains, and BioLife acquisition announcement

Q2 2026 saw 13% organic revenue growth, margin expansion, and strong performance in proteins and analytics. Full-year guidance was raised for revenue and EPS, with BioLife acquisition set to accelerate cell therapy growth and deliver financial synergies.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [BLFS.US](https://longbridge.com/en/quote/BLFS.US.md)
- [RGEN.US](https://longbridge.com/en/quote/RGEN.US.md)

## Related News & Research

- [Repligen says HSR waiting period expires for BioLife Solutions deal](https://longbridge.com/en/news/298368273.md)
- [Repligen CEO Olivier Loeillot disposes of USD 985,896.05 in common shares](https://longbridge.com/en/news/298360540.md)
- [Labcorp buys MLM Medical Labs](https://longbridge.com/en/news/298332531.md)
- [Calviks revises Q2 organic growth to 5.66% from 2.84%](https://longbridge.com/en/news/298204820.md)
- [Chapters Group lifts FY2026 organic adjusted operating EBITDA growth outlook to high-30% range](https://longbridge.com/en/news/298288959.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**